We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
Apply to make changes (a variation) to an existing non-food animal blood bank authorisation (NFABBA).
Apply for authorisation to collect, store, process, produce and administer stem cells for use as an autologous treatment for non-food animals in Great Britain.
Requirements for stock inventories which must be performed regularly.
Good distribution practice for veterinary medicinal products must also be observed by third parties involved in the wholesale distribution of veterinary medicinal products and should be part of their contractual obligations.
Guidance on Pharmacovigilance reporting.
Notification to the VMD if they have a reason to suspect, or know of, a threat to the continued supply of a veterinary medicine.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulati…
Advice for vets: summary position of the Veterinary Medicines Directorate (VMD) on responsible antibiotic use under the prescribing cascade.
The process for the simultaneous review of veterinary drug submissions by Health Canada’s Veterinary Drugs Directorate and the UK's Veterinary Medicines Directorate.
Details of certificates issued under the Special Import System for the top ten veterinary medicines imported 1 January to 31 March 2026.
Actions to be taken by wholesalers and retailers in order to supply medicines to Northern Ireland.
The following detailed requirements shall apply to Requirements for Specific Marketing Authorisation Applications.
This Section lays down specific requirements for identified veterinary medicinal products related to the nature of the active substances contained therein.
Privacy notice regarding personal data processed by the VMD.
Fees calculator tool to help you work out how much your application for a new Marketing Authorisation (MA) or a variation to an existing MA is likely to cost.
Vets can download a poster containing key messages on AMR to use in their surgeries.
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
This document sets out the broad governance framework within which the VMD and Defra operate.
Guidance to the veterinary pharmaceutical industry on moving goods from NI to GB under unfettered access arrangements and placing qualifying NI goods on the GB market.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).